Wheeler Bio, Inc.’s Post

From October 27 to 31, the AIChE Annual Meeting (AIChE - American Institute of Chemical Engineers) is the place to be to engage with worldwide researchers, innovators and thought leaders. Our team will take the opportunity to present how Hovione is bridging science and manufacturing to advance Continuous Tableting for drug product, including the production of precision medicines and breakthrough therapies. To better understand what we are doing for improved efficiency, enhanced process development, and the enablement of faster drug approvals, be sure to attend these oral presentations and meet our experts: 📅 Monday, October 28 Comprehensive Powder Flow Characterization with Reduced Testing, with Maria Paisana, PharmD, PhD 📅 Tuesday, October 29 TSWG Development and Scale up from Laboratory Benchtop Experiments, with Ricardo Sousa 📅 Tuesday, October 29 Scaling Continuous Powder Blenders: The Length-Scale Problem, with Sarang Oka 📅 Wednesday, October 30 Path to Commercial Reality of Continuous Manufacturing - a CDMO Perspective, with José Luís Santos 📅 Wednesday, October 30 Methodology for Rapid Development of a Continuous Loss-in-Weight Feeding Process, with Ana Martins Get to know more about each presentation and authors here: https://lnkd.in/dq667_-V To know more about continuous tableting at Hovione and how our strategic collaboration with GEA Pharma & Healthcare is accelerating industry adoption schedule your meeting: https://lnkd.in/de2Q_eFr #AIChE2024 #continuoustableting #continuousmanufacturing #operationalexcellence #drugproduct #oraldelivery #science #technology #manufacturing #pharmaceutical #cdmo #initforlife

The Pistoia Alliance recently conducted a survey as a pulse check on which laboratory technologies the #pharma / #biotech industry is investing in and companies' progress integrating new tech into their labs. Check out the key findings in this new article by Becky Upton: https://lnkd.in/euazW9XV #drugdevelopment #advancedtechnologies

Unravel the future of life science outsourcing with our 2024 sector and marketing trend report 🧬 Our comprehensive report offers insights from industry experts to help you navigate the challenges and seize the opportunities ahead. Download your copy now 👉 https://loom.ly/dMOfMPA #LifeScienceTrends #Outsourcing #Pharma #Biotech #Innovation

What sets 3Biotech apart from other Chemistry, Manufacturing and Control (CMC) partners? Safety, efficacy, and manufacturability are always at the heart of our approach. We go much further to challenge and support from the very start of our collaboration so our customers can accelerate to reach the next crucial stage and avoid costly pitfalls and delays in the process. You can learn more about some of the benefits of working with us in the slides below with feedback from one of our customers or you can access the full interview with Thierry Bernardi, President of BioFilm Pharma and BioFilm Control via the link below. 👇 https://lnkd.in/ep_P4Ans #customersuccess #CMC #Biotech

Bruce Booth & Atlas Venture are out with their annual year-in-review for #biotech & #pharma. As usual, it's full of interesting stuff, but I was really struck by this slide that shows the hill biopharma companies are climbing. Over the past decade, the average cost to develop a therapy is up by $1 billion. At the same time, success rates have fallen, as has the average value of an approved drug. The science right now is incredibly exciting. Crossed fingers that the other variables required for success -- regulatory frameworks, IP protection, interest rates, etc. -- incentivize break through treatments in 2025 and beyond. The whole presentation is worth your time. https://lnkd.in/eEzQEwDK Recommended, Biorasi!

The ArisGlobal Breakthrough event promises to be an excellent opportunity for interaction with Regulatory peers. We hope you can join us and your colleagues to discover the innovative methods we're employing to enhance the success of Regulatory teams. #regulatoryaffairs #regulatoryoperations

What is the Wheeler Difference? Wheeler Bio, Inc. is bringing a new paradigm to biomanufacturing through our commitment to an open-source, transparent, and predictable service platform made possible by our strong partnership culture. By collaborating with pioneering technology providers and integrating with discovery CROs, we provide our clients with access to the most advanced and effective biomanufacturing solutions while reducing risk and improving efficiency. Collaboration is at the core of the Wheeler model as we believe the only way to build genuine trust is through open communication, unwavering integrity, and consistent results. Let's discuss! In your experience, what are the key factors in building trust with your partners? Let us know in the comments. Explore the Wheeler difference: https://lnkd.in/gAbvMwu5 #pharma #pharmaindustry #biopharma #biotech

In our recent webinar, “Navigating a smarter race to market for oral solid-dose products,” Anil Kane, Ph.D., MBA, Executive Director, Global Head of Technical and Scientific Affairs at Thermo Fisher Scientific, discusses how #CDMOs can support fast and effective scale-up for #biotech and #pharma companies. As Anil addresses, not all CDMOs have the capabilities to scale up activities from early development to commercial production. Therefore, it’s critical for sponsors to sit down with their CDMO partners from the get-go to proactively design scale-up strategies that meet registration, manufacturing, validation, and commercialization goals. To watch the full on-demand #webinar and further explore the importance of #scalability in #drugdevelopment, click here: http://spr.ly/6046k4FPg

Thoughts on this? >> WuXi companies consider sale of units impacted by Biosecure; J&J, Bayer trim staff; Ron Renaud’s latest biotech; and more  >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #productmarketing #biotech #healthcare

𝐒𝐮𝐧𝐭𝐡𝐞𝐭𝐢𝐜𝐬 𝐡𝐚𝐬 𝐜𝐥𝐨𝐬𝐞𝐝 𝐚 $4 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐒𝐞𝐞𝐝 𝐫𝐨𝐮𝐧𝐝 𝐥𝐞𝐝 𝐛𝐲 𝐋'𝐀𝐓𝐓𝐈𝐓𝐔𝐃𝐄 𝐕𝐞𝐧𝐭𝐮𝐫𝐞𝐬 𝐭𝐨 𝐬𝐜𝐚𝐥𝐞 𝐢𝐭𝐬 𝐀𝐈-𝐩𝐨𝐰𝐞𝐫𝐞𝐝 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦. This innovation accelerates pharmaceutical and chemical R&D by streamlining experimentation and reducing costs, cutting time-to-market significantly. Trusted by top companies, Sunthetics is setting new benchmarks for sustainable and efficient chemical development. 𝐇𝐨𝐰 𝐜𝐚𝐧 𝐀𝐈 𝐫𝐞𝐬𝐡𝐚𝐩𝐞 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐜𝐡𝐞𝐦𝐢𝐜𝐚𝐥 𝐚𝐧𝐝 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐑&𝐃? Riya Muckom, Matthew Laferriere, Ramiro Cruz, Hunter Johnson, Rocío Sampayo, Vishaka Shah, David McMullin, Kaivalya Deo, Timothy Mastovich, Pascalia Muli, Fardowsa Kassim, Xing Che, Krishna Vemuri #AIInnovation #ChemicalR&D #PharmaTech ------- 𝐋𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞 𝐡𝐨𝐰 𝐰𝐞 𝐃𝐨 𝐢𝐭 ▶️ https://lnkd.in/ed_mKpkF